Developer docs
API playgroundTry for free, no card

Search company profiles

Wecare

Full company profile

uuid000kvmc

Namestring
Wecare
Legal namestring
Wecare Comércio de Cosméticos Ltda - ME
Websiteurl
wecareskin.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Wecare (legally Wecare Comércio de Cosméticos Ltda - ME) is a Brazilian dermatological products company founded in 2016 and headquartered at Rua Fábia 959, Vila Romana, São Paulo. The company develops and sells skincare formulations specifically engineered for oncology patients undergoing chemotherapy and radiotherapy, addressing dermatological and mucosal side effects such as xerose cutânea (dryness), rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis.

The product portfolio comprises six core SKUs — Washcare (cleansing foam), Moistcare (moisturizing lotion, 100ml and 192ml formats), Extremecare (super-moisturizer, 60g and 120g formats), Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório (oral rinse) — plus five condition-specific kits. All formulations exclude parabens, waxes, fragrances, colorants, and urea, and feature a proprietary active ingredient, Thoitaine (Ergothioneine), a biotechnologically extracted amino acid with antioxidant properties. The company cites over a decade of R&D supported by Brazilian research agencies FAPESC and FINEP, and claims to be the only Brazilian skincare line with clinical studies conducted specifically in cancer patients, reporting 80,000+ patients impacted and inclusion in the Manual de Oncologia Clínica do Brasil (MOC).

Wecare operates a multi-channel go-to-market model: direct e-commerce via wecareskin.com with phone and WhatsApp ordering; retail distribution through the RD Saúde pharmacy chain (Drogasil, Droga Raia) and oncology specialty retailer Oncoshop; hospital channel sales including standardization at Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos; and B2B enterprise partnerships with major pharmaceutical companies (Amgen, Novartis, Libbs) that distribute Wecare products through patient support programs. Individual SKUs are priced between R$96.72 and R$179.92, kits range from R$225 to R$599, and progressive volume discounts are available. The company is privately held, operates with 1–10 employees, and has received at least one disclosed venture investment from Eretz.bio.

Short descriptiontext

Wecare is a Brazilian dermatological company, founded in 2016 and based in São Paulo, that develops and sells oncology-specific skincare formulations for patients undergoing chemotherapy and radiotherapy, distributed through hospitals, pharmacy chains, pharma patient support programs, and direct e-commerce.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSão Paulo, Brazil
HQ citystring
São Paulo
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology skincare products, chemotherapy skin care, radiotherapy dermatological care, oral mucositis treatment, medical cosmetics
Industry3 codes
PRIMARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code1 code
  • Cosmetics, Beauty Supplies, and Perfume Retailers456120
SIC code1 code
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Oncology Skincare Products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct product sales
TypeOne Time License
Description

E-commerce sales of skincare products directly to oncology patients and their caregivers through the company website.

Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel
Pricing details2 tiers
1Individual products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Washcare R$133.12; Moistcare 100ml R$118.56; Moistcare 192ml R$171.60; Oralcare Gel R$128.96; Oralcare Enxaguatório R$117.52; Extremecare 60g R$96.72; Extremecare 120g R$169.52; Coolcare Mask R$179.92

2Specialized kits for chemotherapy
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Kit Quimioterapia R$427.00; Kit Mãos e Pés R$279.00; Kit Rash Cutâneo R$279.00; Kit Quimio e Rádio R$599.00; Kit Cuidados Orais R$225.00

wecareskin.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Wecare develops, manufactures, and sells dermatological skincare and oral care products specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. The product line addresses skin and mucosal complications including xerose cutânea, rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis. Products are sold directly to consumers via e-commerce, through pharmacy chains, oncology hospitals, and specialty oncology retailers, with clinical evidence supporting efficacy in cancer patient populations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 100% of patients in clinical studies maintained their oncology treatment without interruptions or dose reductions
+3 more records
Product overview1 text field

Wecare is a Brazilian skincare product line specifically developed for oncology patients undergoing chemotherapy and radiotherapy. The product portfolio consists of six core products (Washcare, Moistcare, Extremecare, Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório) and five specialized kits for different treatment needs. The products are formulated without parabens, fragrances, dyes, or other aggressive ingredients, and are the only line in Brazil with clinical studies conducted specifically in cancer patients. The company has partnerships with major Brazilian cancer hospitals including Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos.

Product and service12 records
1Washcare
CategorySkin cleansing
Description

Cleaning foam for sensitive, dry, or irritated skin during chemotherapy and radiotherapy, formulated with natural amino acids, Aloe Vera, and Calendula oil for gentle cleansing without stripping moisture. Targeted at oncology patients experiencing skin sensitivity.

2Moistcare
CategorySkin moisturizing
Description

Moisturizing lotion (100ml and 192ml sizes) for red, painful, and dry skin during chemotherapy and radiotherapy. Contains Hazelnut oil, Calendula, Shea butter, Aloe Vera, Chamomile, Oat, Vitamin E, and Thoitaine for deep hydration and skin recovery. Targeted at oncology patients with dermatological side effects.

3Extremecare
CategorySkin moisturizing
Description

Super-moisturizer (60g and 120g sizes) for extremely dry, peeling, or itchy skin caused by chemotherapy or radiotherapy. Formulated with Glycerin, Hazelnut oil, Calendula oil, Shea butter, Chamomile, Oat, Aloe Vera, Vitamin E, and Thoitaine. Targeted at oncology patients with severe skin dryness.

4Coolcare Mask
CategorySkin treatment mask
Description

Calming mask to relieve hot, burning, and sensitive skin sensation during radiotherapy. Provides immediate refreshing sensation and prolonged comfort with Aloe Vera, Calendula oil, and Frescolat. Targeted at radiotherapy patients experiencing radiodermite and burning.

5Oralcare Gel
CategoryOral care
Description

Oral gel for treatment of active oral mucosal lesions. Contains Demineralized Water, Glycerin, Hytellose, Glutamine, Xylitol, Sodium Benzoate, Potassium Sorbate, and Hydrolyzed Hyaluronic Acid. Targeted at oncology patients experiencing oral mucositis.

6Oralcare Enxaguatório
CategoryOral care
Description

Alcohol-free and dye-free oral rinse for prevention and care of oral mucositis. Contains L-Glutamine, Sodium Fluoride (1356.75 ppm fluoride), and Xylitol. Targeted at oncology patients at risk of oral mucosal complications.

7Kit Pele na Quimioterapia (Chemotherapy Skin Care Kit)
CategoryTreatment kit
Description

Specialized kit for treatment and prevention of skin dryness in chemotherapy patients, including Washcare, Extremecare, and Moistcare for complete skin care. Targeted at chemotherapy patients at a bundled price (R$427.00).

8Kit Pele na Quimio e Rádio (Chemo and Radio Skin Care Kit)
CategoryTreatment kit
Description

Comprehensive kit for care and prevention of side effects on skin from chemotherapy and radiotherapy, including Washcare, Extremecare, Moistcare, and Coolcare Mask. Targeted at patients undergoing both treatments (R$599.00).

9Kit Mãos e Pés Ressecados pela Quimio (Dry Hands and Feet Chemo Kit)
CategoryTreatment kit
Description

Kit for treatment and prevention of dry hands and feet in cancer patients, addressing Hand-Foot Syndrome with Washcare and Extremecare. Targeted at chemotherapy patients experiencing hand-foot syndrome (R$279.00).

10Kit Rash Cutâneo (Cutaneous Rash Kit)
CategoryTreatment kit
Description

Kit for care and prevention of cutaneous rash associated with chemotherapy, helping reduce irritation, sensitivity, and dermatological discomfort. Targeted at chemotherapy patients experiencing rash (R$279.00).

11Kit de Cuidados Orais (Oral Care Kit)
CategoryTreatment kit
Description

Oral care kit for prevention and care of mucositis, oral sensitivity, and mucosal dryness, including Oralcare Gel and Oralcare Enxaguatório. Targeted at oncology patients with oral complications (R$225.00).

12Kit Pele na Radioterapia (Radiotherapy Skin Care Kit)
CategoryTreatment kit
Description

Specialized kit for treatment and prevention of skin dryness in radiotherapy patients. Targeted at radiotherapy patients experiencing skin side effects (R$451.00).

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Hospital Israelita Albert Einstein
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wecare is the only skincare line with standardized products at Hospital Israelita Albert Einstein, one of Brazil's most prestigious hospitals. Products are part of prescribed care protocols.

wecareskin.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wecare is the only skincare line with standardized products at Hospital de Amor de Barretos. Products are included in prescribed care and patient support protocols.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wecare products are present and prescribed at ICESP, part of the state cancer institute network in São Paulo.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Products indicated and acquired by Amgen for patient support programs during cancer treatment.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Products indicated and acquired by Novartis for patient support programs during cancer treatment.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Products indicated and acquired by Libbs for patient support programs during cancer treatment.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Major pharmacy chain distribution partnership covering Drogasil and Droga Raia retail locations throughout Brazil.

8Oncoshop
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Specialty oncology retailer for direct patient access to Wecare products.

wecareskin.com
9Dr. Antonio Carlos Buzaid
Strategic tierCoreTypeOthers
Description

Editor of Manual de Oncologia Clínica do Brasil (MOC), serves as a key medical reference for the Wecare ecosystem.

wecareskin.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Lindi Skin is a US-based skincare brand specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. Directly comparable to Wecare in vertical specialization, product categories (cleansers, moisturizers, body products), and clinical-evidence-led positioning.

TypeEmerging player
Description

Hope for Hair and similar niche oncology-supportive brands develop scalp and skin products targeted at cancer patients, including scalp care during chemo-induced hair loss. Comparable to Wecare in addressing dermatological side effects of cancer therapy, though narrower in product scope.

TypeBroad incumbent
Description

La Roche-Posay is a global dermocosmetic leader with a dedicated oncology-support skincare range. Comparable to Wecare through overlapping target population (sensitive/compromised skin) and medical-grade positioning, though it operates as a broad incumbent rather than a niche oncology specialist.

TypeBroad incumbent
Description

Avène offers dermatological skincare lines for sensitive skin with products often used during medical treatments. Comparable through its clinical, dermatology-led brand positioning and overlap with Wecare's sensitive-skin patient base.

TypeBroad incumbent
Description

Eucerin is a medical skincare brand offering products for dry, compromised, and sensitive skin, including ranges positioned for skin barrier repair. Overlaps with Wecare's hydration and barrier-restoration use cases for oncology patients.

TypeBroad incumbent
Description

Galderma is a global dermatology-focused company offering prescription and consumer skincare. Comparable through its dermatological specialization and presence in sensitive-skin and skin-barrier categories relevant to oncology patients.

TypeBroad incumbent
Description

CeraVe offers dermatologist-recommended skincare with ceramides for skin barrier repair. Comparable through its positioning for compromised skin and pharmacy-distribution model, overlapping with Wecare's go-to-market and ingredient philosophy.

TypeOthers
Description

Viatris (and similar generic/specialty pharma players) operate patient-support programs that bundle supportive care products alongside oncology therapeutics. Comparable to Wecare as a counterparty in pharma patient-support ecosystems, similar to Wecare's relationships with Amgen, Novartis, and Libbs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wecare

Oncology Skincare Productswecareskin.com

Wecare is a Brazilian dermatological company, founded in 2016 and based in São Paulo, that develops and sells oncology-specific skincare formulations for patients undergoing chemotherapy and radiotherapy, distributed through hospitals, pharmacy chains, pharma patient support programs, and direct e-commerce.

What Wecare does

Wecare (legally Wecare Comércio de Cosméticos Ltda - ME) is a Brazilian dermatological products company founded in 2016 and headquartered at Rua Fábia 959, Vila Romana, São Paulo. The company develops and sells skincare formulations specifically engineered for oncology patients undergoing chemotherapy and radiotherapy, addressing dermatological and mucosal side effects such as xerose cutânea (dryness), rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis.

The product portfolio comprises six core SKUs — Washcare (cleansing foam), Moistcare (moisturizing lotion, 100ml and 192ml formats), Extremecare (super-moisturizer, 60g and 120g formats), Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório (oral rinse) — plus five condition-specific kits. All formulations exclude parabens, waxes, fragrances, colorants, and urea, and feature a proprietary active ingredient, Thoitaine (Ergothioneine), a biotechnologically extracted amino acid with antioxidant properties. The company cites over a decade of R&D supported by Brazilian research agencies FAPESC and FINEP, and claims to be the only Brazilian skincare line with clinical studies conducted specifically in cancer patients, reporting 80,000+ patients impacted and inclusion in the Manual de Oncologia Clínica do Brasil (MOC).

Wecare operates a multi-channel go-to-market model: direct e-commerce via wecareskin.com with phone and WhatsApp ordering; retail distribution through the RD Saúde pharmacy chain (Drogasil, Droga Raia) and oncology specialty retailer Oncoshop; hospital channel sales including standardization at Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos; and B2B enterprise partnerships with major pharmaceutical companies (Amgen, Novartis, Libbs) that distribute Wecare products through patient support programs. Individual SKUs are priced between R$96.72 and R$179.92, kits range from R$225 to R$599, and progressive volume discounts are available. The company is privately held, operates with 1–10 employees, and has received at least one disclosed venture investment from Eretz.bio.

Wecare firmographics

Firmographics
Name
Wecare
Legal name
Wecare Comércio de Cosméticos Ltda - ME
Website
https://wecareskin.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Wecare is a Brazilian dermatological company, founded in 2016 and based in São Paulo, that develops and sells oncology-specific skincare formulations for patients undergoing chemotherapy and radiotherapy, distributed through hospitals, pharmacy chains, pharma patient support programs, and direct e-commerce.
Ownership category
akta.pro rank

Wecare industry classification

Industry
Product category
Oncology Skincare Products
NAICS
Cosmetics, Beauty Supplies, and Perfume Retailers (456120)
SIC
Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro industry
PRIMARYCRABAAAB
Treatment Skincare (Serums, Actives, Acne & Anti-aging)
SECONDARYCRABAAAF
Dermocosmetics & Medical-Grade Skincare
SECONDARYCRADAMAF
Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Oncology skincare products
  • Chemotherapy skin care
  • Radiotherapy dermatological care
  • Oral mucositis treatment
  • Medical cosmetics

Where Wecare is headquartered

Location

Headquarters

HQ city
São Paulo
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Wecare business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

  1. Direct product sales: E-commerce sales of skincare products directly to oncology patients and their caregivers through the company website.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual products
Unit PricingPay-as-you-goSpecialized kits for chemotherapy

Go-to-market motion1 record

Distribution channels5 records

Marketing channels4 records

Wecare product offering

Product offering

Core offering

Wecare develops, manufactures, and sells dermatological skincare and oral care products specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. The product line addresses skin and mucosal complications including xerose cutânea, rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis. Products are sold directly to consumers via e-commerce, through pharmacy chains, oncology hospitals, and specialty oncology retailers, with clinical evidence supporting efficacy in cancer patient populations.

Product overview

Wecare is a Brazilian skincare product line specifically developed for oncology patients undergoing chemotherapy and radiotherapy. The product portfolio consists of six core products (Washcare, Moistcare, Extremecare, Coolcare Mask, Oralcare Gel, and Oralcare Enxaguatório) and five specialized kits for different treatment needs. The products are formulated without parabens, fragrances, dyes, or other aggressive ingredients, and are the only line in Brazil with clinical studies conducted specifically in cancer patients. The company has partnerships with major Brazilian cancer hospitals including Hospital Israelita Albert Einstein, ICESP, and Hospital de Amor de Barretos.

Differentiator

Problem solved

Functional benefit

Products and services

  • Washcare Cleaning foam for sensitive, dry, or irritated skin during chemotherapy and radiotherapy, formulated with natural amino acids, Aloe Vera, and Calendula oil for gentle cleansing without stripping moisture. Targeted at oncology patients experiencing skin sensitivity.
  • Moistcare Moisturizing lotion (100ml and 192ml sizes) for red, painful, and dry skin during chemotherapy and radiotherapy. Contains Hazelnut oil, Calendula, Shea butter, Aloe Vera, Chamomile, Oat, Vitamin E, and Thoitaine for deep hydration and skin recovery. Targeted at oncology patients with dermatological side effects.
  • Extremecare Super-moisturizer (60g and 120g sizes) for extremely dry, peeling, or itchy skin caused by chemotherapy or radiotherapy. Formulated with Glycerin, Hazelnut oil, Calendula oil, Shea butter, Chamomile, Oat, Aloe Vera, Vitamin E, and Thoitaine. Targeted at oncology patients with severe skin dryness.
  • Coolcare Mask Calming mask to relieve hot, burning, and sensitive skin sensation during radiotherapy. Provides immediate refreshing sensation and prolonged comfort with Aloe Vera, Calendula oil, and Frescolat. Targeted at radiotherapy patients experiencing radiodermite and burning.
  • Oralcare Gel Oral gel for treatment of active oral mucosal lesions. Contains Demineralized Water, Glycerin, Hytellose, Glutamine, Xylitol, Sodium Benzoate, Potassium Sorbate, and Hydrolyzed Hyaluronic Acid. Targeted at oncology patients experiencing oral mucositis.
  • Oralcare Enxaguatório Alcohol-free and dye-free oral rinse for prevention and care of oral mucositis. Contains L-Glutamine, Sodium Fluoride (1356.75 ppm fluoride), and Xylitol. Targeted at oncology patients at risk of oral mucosal complications.
  • Kit Pele na Quimioterapia (Chemotherapy Skin Care Kit) Specialized kit for treatment and prevention of skin dryness in chemotherapy patients, including Washcare, Extremecare, and Moistcare for complete skin care. Targeted at chemotherapy patients at a bundled price (R$427.00).
  • Kit Pele na Quimio e Rádio (Chemo and Radio Skin Care Kit) Comprehensive kit for care and prevention of side effects on skin from chemotherapy and radiotherapy, including Washcare, Extremecare, Moistcare, and Coolcare Mask. Targeted at patients undergoing both treatments (R$599.00).
  • Kit Mãos e Pés Ressecados pela Quimio (Dry Hands and Feet Chemo Kit) Kit for treatment and prevention of dry hands and feet in cancer patients, addressing Hand-Foot Syndrome with Washcare and Extremecare. Targeted at chemotherapy patients experiencing hand-foot syndrome (R$279.00).
  • Kit Rash Cutâneo (Cutaneous Rash Kit) Kit for care and prevention of cutaneous rash associated with chemotherapy, helping reduce irritation, sensitivity, and dermatological discomfort. Targeted at chemotherapy patients experiencing rash (R$279.00).
  • Kit de Cuidados Orais (Oral Care Kit) Oral care kit for prevention and care of mucositis, oral sensitivity, and mucosal dryness, including Oralcare Gel and Oralcare Enxaguatório. Targeted at oncology patients with oral complications (R$225.00).
  • Kit Pele na Radioterapia (Radiotherapy Skin Care Kit) Specialized kit for treatment and prevention of skin dryness in radiotherapy patients. Targeted at radiotherapy patients experiencing skin side effects (R$451.00).

Quantifiable outcome

  • 100% of patients in clinical studies maintained their oncology treatment without interruptions or dose reductions
  • +3 more outcomes

Companies that use Wecare

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles4 records

Wecare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Wecare partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and major.

  • Hospital Israelita Albert EinsteincoreStrategic or Co-development PartnerWecare is the only skincare line with standardized products at Hospital Israelita Albert Einstein, one of Brazil's most prestigious hospitals. Products are part of prescribed care protocols.
  • Hospital de Amor (Barretos)coreStrategic or Co-development PartnerWecare is the only skincare line with standardized products at Hospital de Amor de Barretos. Products are included in prescribed care and patient support protocols.
  • ICESP (Instituto do Câncer do Estado de São Paulo)coreStrategic or Co-development PartnerWecare products are present and prescribed at ICESP, part of the state cancer institute network in São Paulo.
  • AmgenmajorGTM or Marketing PartnerProducts indicated and acquired by Amgen for patient support programs during cancer treatment.
  • NovartismajorGTM or Marketing PartnerProducts indicated and acquired by Novartis for patient support programs during cancer treatment.
  • LibbsmajorGTM or Marketing PartnerProducts indicated and acquired by Libbs for patient support programs during cancer treatment.
  • RD Saúde (Drogasil, Droga Raia)majorChannel Partner/ Reseller/ DistributorMajor pharmacy chain distribution partnership covering Drogasil and Droga Raia retail locations throughout Brazil.
  • OncoshopcoreChannel Partner/ Reseller/ DistributorSpecialty oncology retailer for direct patient access to Wecare products.
  • Dr. Antonio Carlos BuzaidcoreOthersEditor of Manual de Oncologia Clínica do Brasil (MOC), serves as a key medical reference for the Wecare ecosystem.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Wecare competitors and assessment

Company assessment

Direct peers

  • Lindi Skin: Lindi Skin is a US-based skincare brand specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. Directly comparable to Wecare in vertical specialization, product categories (cleansers, moisturizers, body products), and clinical-evidence-led positioning.

Emerging players

  • Hope for Hair / 4 Thoughts (oncology skincare): Hope for Hair and similar niche oncology-supportive brands develop scalp and skin products targeted at cancer patients, including scalp care during chemo-induced hair loss. Comparable to Wecare in addressing dermatological side effects of cancer therapy, though narrower in product scope.

Broad incumbents

  • La Roche-Posay: La Roche-Posay is a global dermocosmetic leader with a dedicated oncology-support skincare range. Comparable to Wecare through overlapping target population (sensitive/compromised skin) and medical-grade positioning, though it operates as a broad incumbent rather than a niche oncology specialist.
  • Avène (Pierre Fabre): Avène offers dermatological skincare lines for sensitive skin with products often used during medical treatments. Comparable through its clinical, dermatology-led brand positioning and overlap with Wecare's sensitive-skin patient base.
  • Eucerin (Beiersdorf): Eucerin is a medical skincare brand offering products for dry, compromised, and sensitive skin, including ranges positioned for skin barrier repair. Overlaps with Wecare's hydration and barrier-restoration use cases for oncology patients.
  • Galderma: Galderma is a global dermatology-focused company offering prescription and consumer skincare. Comparable through its dermatological specialization and presence in sensitive-skin and skin-barrier categories relevant to oncology patients.
  • CeraVe: CeraVe offers dermatologist-recommended skincare with ceramides for skin barrier repair. Comparable through its positioning for compromised skin and pharmacy-distribution model, overlapping with Wecare's go-to-market and ingredient philosophy.

Others

  • Mylan/Viatris Oncology Support: Viatris (and similar generic/specialty pharma players) operate patient-support programs that bundle supportive care products alongside oncology therapeutics. Comparable to Wecare as a counterparty in pharma patient-support ecosystems, similar to Wecare's relationships with Amgen, Novartis, and Libbs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Wecare social profiles

Digital presence

Wecare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wecare leadership team

Management profile

Number of profiles

Wecare funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wecare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wecare

What does Wecare do?

Wecare develops, manufactures, and sells dermatological skincare and oral care products specifically formulated for oncology patients undergoing chemotherapy and radiotherapy. The product line addresses skin and mucosal complications including xerose cutânea, rash cutâneo, radiodermite, hand-foot syndrome, and oral mucositis. Products are sold directly to consumers via e-commerce, through pharmacy chains, oncology hospitals, and specialty oncology retailers, with clinical evidence supporting efficacy in cancer patient populations.

Is Wecare a public or private company?

Wecare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Wecare founded?

Wecare was founded in 2016. It employs 11 to 50 people.

Where is Wecare based?

Wecare is headquartered in São Paulo, Brazil, in the Latin America region.

How does Wecare make money?

One revenue line is on record: direct product sales.

Who are Wecare's main competitors?

Lindi Skin is listed as a direct peer. Hope for Hair / 4 Thoughts (oncology skincare) is listed as an emerging player. Broad incumbents are La Roche-Posay, Avène (Pierre Fabre), Eucerin (Beiersdorf), Galderma and CeraVe. Mylan/Viatris Oncology Support is listed as an others.

Does Wecare have an API?

No public API is recorded for Wecare.

What industry is Wecare in?

Wecare's product category is Oncology Skincare Products. Its primary akta.pro industry code is CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging), with a secondary code of CRABAAAF, Dermocosmetics & Medical-Grade Skincare. Its NAICS code is 456120 and its SIC code is 2844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales